Literature DB >> 17293352

N-glycans of recombinant human acid alpha-glucosidase expressed in the milk of transgenic rabbits.

Susanne P Jongen1, Gerrit J Gerwig, Bas R Leeflang, Kate Koles, Maurice L M Mannesse, Patrick H C van Berkel, Frank R Pieper, Marian A Kroos, Arnold J J Reuser, Qun Zhou, Xiaoying Jin, Kate Zhang, Tim Edmunds, Johannis P Kamerling.   

Abstract

Pompe disease is a lysosomal glycogen storage disorder characterized by acid alpha-glucosidase (GAA) deficiency. More than 110 different pathogenic mutations in the gene encoding GAA have been observed. Patients with this disease are being treated by intravenous injection of recombinant forms of the enzyme. Focusing on recombinant approaches to produce the enzyme means that specific attention has to be paid to the generated glycosylation patterns. Here, human GAA was expressed in the mammary gland of transgenic rabbits. The N-linked glycans of recombinant human GAA (rhAGLU), isolated from the rabbit milk, were released by peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase F. The N-glycan pool was fractionated and purified into individual components by a combination of anion-exchange, normal-phase, and Sambucus nigra agglutinin-affinity chromatography. The structures of the components were analyzed by 500 MHz one-dimensional and 600 MHz cryo two-dimensional (total correlation spectroscopy [TOCSY] nuclear Overhauser enhancement spectroscopy) (1)H nuclear magnetic resonance spectroscopy, combined with two-dimensional (31)P-filtered (1)H-(1)H TOCSY spectroscopy, matrix-assisted laser desorption ionization time-of-flight mass spectrometry, and high-performance liquid chromatography (HPLC)-profiling of 2-aminobenzamide-labeled glycans combined with exoglycosidase digestions. The recombinant rabbit glycoprotein contained a broad array of different N-glycans, comprising oligomannose-, hybrid-, and complex-type structures. Part of the oligomannose-type glycans showed the presence of phospho-diester-bridged N-acetylglucosamine. For the complex-type glycans (partially) (alpha2-6)-sialylated (nearly only N-acetylneuraminic acid) diantennary structures were found; part of the structures were (alpha1-6)-core-fucosylated or (alpha1-3)-fucosylated in the upper antenna (Lewis x). Using HPLC-mass spectrometry of glycopeptides, information was generated with respect to the site-specific location of the various glycans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17293352     DOI: 10.1093/glycob/cwm015

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  6 in total

Review 1.  Treatment of lysosomal storage disorders : progress with enzyme replacement therapy.

Authors:  Marianne Rohrbach; Joe T R Clarke
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Biochemical and pharmacological characterization of different recombinant acid alpha-glucosidase preparations evaluated for the treatment of Pompe disease.

Authors:  A J McVie-Wylie; K L Lee; H Qiu; X Jin; H Do; R Gotschall; B L Thurberg; C Rogers; N Raben; M O'Callaghan; W Canfield; L Andrews; J M McPherson; R J Mattaliano
Journal:  Mol Genet Metab       Date:  2008-06-05       Impact factor: 4.797

3.  Endolysosomal N-glycan processing is critical to attain the most active form of the enzyme acid alpha-glucosidase.

Authors:  Nithya Selvan; Nickita Mehta; Suresh Venkateswaran; Nastry Brignol; Matthew Graziano; M Osman Sheikh; Yuliya McAnany; Finn Hung; Matthew Madrid; Renee Krampetz; Nicholas Siano; Anuj Mehta; Jon Brudvig; Russell Gotschall; Jill M Weimer; Hung V Do
Journal:  J Biol Chem       Date:  2021-05-07       Impact factor: 5.157

Review 4.  Carbohydrate analysis throughout the development of a protein therapeutic.

Authors:  Elizabeth Higgins
Journal:  Glycoconj J       Date:  2009-11-04       Impact factor: 2.916

5.  Expression systems and species used for transgenic animal bioreactors.

Authors:  Yanli Wang; Sihai Zhao; Liang Bai; Jianglin Fan; Enqi Liu
Journal:  Biomed Res Int       Date:  2013-03-17       Impact factor: 3.411

6.  N-/O-glycosylation analysis of human FVIIa produced in the milk of transgenic rabbits.

Authors:  Guillaume Chevreux; Valegh Faid; Jean-Marc Scohyers; Nicolas Bihoreau
Journal:  Glycobiology       Date:  2013-10-02       Impact factor: 4.313

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.